Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Biochemical Pharmacology|September 6, 2011
M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastropheBenny J Evison, Mile Pastuovic, Rebecca A Bilardi, et al.Bioorganic & Medicinal Chemistry Letters|April 6, 2005
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binderRenee N Brown, Rachel Cameron, David K Chalmers, et al.Journal of Medicinal Chemistry|September 24, 2010
New anthracenedione derivatives with improved biological activity by virtue of stable drug-DNA adduct formationOula C Mansour, Benny J Evison, Brad E Sleebs, et al.Antimicrobial Agents and Chemotherapy|April 15, 2009
Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activityGeorgina A Holloway, William N Charman, Alan H Fairlamb, et al.ACS Medicinal Chemistry Letters|June 6, 2014
An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human RhinovirusSusanne C Feil, Stephanie Hamilton, Guy Y Krippner, et al.Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidaseKeith G Watson, Rachel Cameron, Rob J Fenton, et al.Journal of Medicinal Chemistry|July 11, 2003
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirusKeith G Watson, Renee N Brown, Rachel Cameron, et al.Nature Chemical Biology|April 23, 2013
Structure-guided design of a selective BCL-X(L) inhibitorGuillaume Lessene, Peter E Czabotar, Brad E Sleebs, et al.Antimicrobial Agents and Chemotherapy|November 25, 2004
Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimenSimon J F Macdonald, Keith G Watson, Rachel Cameron, et al.Journal of Medicinal Chemistry|April 15, 2005
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenzaSimon J F Macdonald, Rachel Cameron, Derek A Demaine, et al.Pageof 3